A detailed history of Ancora Advisors, LLC transactions in Omeros Corp stock. As of the latest transaction made, Ancora Advisors, LLC holds 118,534 shares of OMER stock, worth $481,248. This represents 0.01% of its overall portfolio holdings.

Number of Shares
118,534
Previous 163,023 27.29%
Holding current value
$481,248
Previous $533,000 23.45%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.88 - $4.89 $128,128 - $217,551
-44,489 Reduced 27.29%
118,534 $408,000
Q4 2023

Feb 14, 2024

SELL
$1.08 - $3.63 $50,760 - $170,610
-47,000 Reduced 22.38%
163,023 $533,000
Q3 2023

Nov 14, 2023

BUY
$2.81 - $5.69 $110,924 - $224,612
39,475 Added 23.15%
210,023 $613,000
Q2 2023

Aug 14, 2023

SELL
$4.45 - $7.57 $280,212 - $476,675
-62,969 Reduced 26.97%
170,548 $927,000
Q1 2023

May 15, 2023

SELL
$2.48 - $5.22 $224,440 - $472,410
-90,500 Reduced 27.93%
233,517 $1.09 Million
Q4 2022

Feb 14, 2023

BUY
$1.75 - $3.96 $312,016 - $706,048
178,295 Added 122.35%
324,017 $732,000
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $418,633 - $1.01 Million
-135,480 Reduced 48.18%
145,722 $459,000
Q2 2022

Aug 15, 2022

BUY
$1.92 - $6.28 $325,900 - $1.07 Million
169,740 Added 152.29%
281,202 $773,000
Q1 2022

May 16, 2022

BUY
$5.07 - $7.2 $565,112 - $802,526
111,462 New
111,462 $670,000
Q1 2022

May 13, 2022

SELL
$5.07 - $7.2 $739,140 - $1.05 Million
-145,787 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.67 - $8.54 $64,711 - $97,467
11,413 Added 8.49%
145,787 $937,000
Q2 2021

Aug 13, 2021

BUY
$14.81 - $19.13 $1.99 Million - $2.57 Million
134,374 New
134,374 $1.99 Million
Q1 2021

May 14, 2021

SELL
$14.52 - $23.53 $483,951 - $784,254
-33,330 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$10.14 - $15.19 $30 - $45
-3 Reduced 0.01%
33,330 $476,000
Q3 2020

Nov 13, 2020

BUY
$9.57 - $21.32 $318,996 - $710,659
33,333 New
33,333 $337,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $255M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.